Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. - Wikidata - awgldk - TriplyDB

Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo.

Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo.

http://www.wikidata.org/entity/Q43562610

about

Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy Novel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat model Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study.Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.Autoantibodies and cardiovascular dysfunction: cause or consequence?Effect of prazosin on diabetic nephropathy patients with positive α1-adrenergic receptor autoantibodies and refractory hypertension.Adoptive passive transfer of rabbit beta1-adrenoceptor peptide immune cardiomyopathy into the Rag2-/- mouse: participation of the ER stress.Autoantibodies against β1-adrenoceptor induce blood glucose enhancement and insulin insufficient via T lymphocytes Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.Pathological autoantibodies in cardiomyopathy.Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.Inducible cardiac arrhythmias caused by enhanced β1-adrenergic autoantibody expression in the rabbit.MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression.Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy Is overall blockade superior to selective blockade of adrenergic receptor subtypes in suppressing left ventricular remodeling in spontaneously hypertensive rats?Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy.Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure.Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β1-Adrenergic Receptors.The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology.

P2860

Q24652847-804BACDD-A069-4813-A59C-B35F4A40A4F4 Q27000434-82FFA01F-6D76-49CD-ABA2-260AACCF3DD2 Q27315858-2D46293F-8EE8-4811-B508-C5C0A98883D7 Q30989751-1F5D81B6-818A-465D-9833-4DF6078A217A Q33568986-4D0EF09E-F319-4554-8D6F-88460F762ABC Q34473885-8146BC1C-C64F-4731-A0CB-92A772A957B8 Q34585190-425444A3-2C81-4AFA-B5C2-376F1A8D2BF5 Q36665715-CCF56FA4-D38A-48DB-9BFD-06EF1E777E90 Q36678532-6490814B-82CC-4654-9AF1-A441BD6225A2 Q36971570-B590DDF2-5910-4985-84CB-97F104B7C8EB Q37264371-389BFE6B-C892-4E46-BF47-C667EBAAC83E Q37441193-391BA5E8-81CD-4AE5-AE30-4D13CD79908D Q37575917-1A3C9EA3-63D7-4C5A-990D-AA6767F0E9CE Q37690123-B12432EC-FD1D-4CD0-B1FF-A344DF95FD0D Q40841949-82EC7595-EBAA-42EC-AAE2-CCF9A8C4061C Q42953231-E551123A-F0B5-4EC1-AF3C-931030CC97BC Q43626109-7D7F4E4A-D4E9-4688-AA7E-D0684868835A Q46871343-D0A65CA8-BFB3-459F-BB0A-6717AB39B605 Q51125254-89299FDA-A6A4-4B63-BB03-088714B703BD Q55318081-8163DEA4-69C4-4944-8EEB-0BD8DBB4C502

P2860

Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo.

http://www.wikidata.org/entity/Q43562610

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Autoimmunity against the secon ...... yocardial hypertrophy in vivo.

@en

type

label

Autoimmunity against the secon ...... yocardial hypertrophy in vivo.

@en

prefLabel

Autoimmunity against the secon ...... yocardial hypertrophy in vivo.

@en

P1433

Q43562610-7904F05E-8BA0-4E57-AA66-AF99751E38D7

P1476

Q43562610-3FA2525C-13C0-4EE3-95B8-FCBFE92B29AD

P2093

Q43562610-1008BB6F-7AE0-464C-B544-FAD27161CFF3

Q43562610-3435FDAD-A4A8-4997-A5A2-40D8579D903C

Q43562610-394A589D-A9F0-4A71-BF15-C55EAA6102D4

Q43562610-406A3687-5520-4A3D-B50C-F0534566860F

Q43562610-42407043-6357-4442-8752-307167DB953B

Q43562610-7286FD9D-19EC-4BAA-B8F9-5CB057B248FA

Q43562610-8FA6ACC0-4D28-4196-9E7C-0CFF22EA66FD

Q43562610-CDDDCAFB-2697-4DC9-B5AF-1338A153D9A3

P304

Q43562610-2920796A-0992-43A1-8549-087C5B330810

P31

Q43562610-F22C9DA0-23A1-479C-AB67-E563AFC49B90

P356

Q43562610-6A52988C-B61E-4105-AF23-45758B73FA8A

P433

Q43562610-F1329294-53F0-4D01-94D9-04B9E873E8E1

P478

Q43562610-C1736C9B-78C4-4C63-9B3F-7FE53AFF5C71

P577

Q43562610-96B8537E-8BE6-4CA5-B48B-B07392F46D6E

P698

Q43562610-759532EB-0AE6-4BFD-9389-9FFCB185ED7F

P356

01.RES.88.6.578

P1433

Circulation Research

P1476

Autoimmunity against the secon ...... yocardial hypertrophy in vivo.

@en

P2093

Anzai T

http://www.w3.org/2001/XMLSchema#string

Baba A

http://www.w3.org/2001/XMLSchema#string

Iwata M

http://www.w3.org/2001/XMLSchema#string

Nakamura I

http://www.w3.org/2001/XMLSchema#string

Ogawa S

http://www.w3.org/2001/XMLSchema#string

Takahashi T

http://www.w3.org/2001/XMLSchema#string

Wainai Y

http://www.w3.org/2001/XMLSchema#string

Yoshikawa T

http://www.w3.org/2001/XMLSchema#string

P304

578-586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.88.6.578

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11282891

http://www.w3.org/2001/XMLSchema#string